Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Cyntellect $1.3M for Cell Cloning Technology Development

NEW YORK (GenomeWeb News) - Cyntellect said today it has received a Phase II Small Business Innovative Research grant from the National Cancer Institute worth $1.3 million to develop applications for its LEAP cell-imaging system.
 
LEAP (Laser-Enabled Analysis and Processing) is designed for high-throughput cell imaging and laser-based cell manipulation, the company said.
 
Cyntellect, based in San Diego, said it will use the award to develop applications that use LEAP for high-speed purification and cell cloning based on the secretion of native or recombinant proteins.
 
This capability should enable users to generate cell samples for biomarker and gene expression studies, develop cell lines for functional screening assays, improve efficiency in protein production, and other applications, Cyntellect said.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.